Titled “The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond.”, a piece appearing in the January, 2013 edition of Human Reproduction by A.D. Domar and a team from Harvard Medical School provides important insight into the link between gestational exposure to selective serotonin reuptake inhibitor drugs (SSRIs) and poor birth outcomes.
Reviewing previously-published literature, the team found that “Antidepressant use during pregnancy is associated with increased risks of miscarriage, birth defects, preterm birth, newborn behavioral syndrome, persistent pulmonary hypertension of the newborn and possible longer term neurobehavioral effects.” (emphasis added)
It is also warned that “There is no evidence of improved pregnancy outcomes with antidepressant use.”
Because the manufacturers of many SSRI drugs like Prozac, Paxil, and Zoloft have failed time and again to warn women of these and other serious risks, thousands of SSRI birth defect lawsuits have been filed around the world.
If you or a loved one used SSRIs and gave birth to a child with a congenital malformation or who had perinatal complications, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of SSRI birth defect lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529